Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.67
Delayed Data
As of Jul 26
 +0.01 / +0.60%
Today’s Change
1.30
Today|||52-Week Range
4.17
-12.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues9.2M9.1M7.8M9.8M
 
 
 
 
 
Cost of Goods Sold528.0K710.0K754.0K1.2M
 
 
 
 
 
Depreciation And Amortization2.6M2.5M2.5M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income6.1M5.9M4.5M6.2M
 
 
 
 
 
General Expenses33.0M31.1M29.8M25.4M
 
 
 
 
 
Research And Development24.2M22.1M20.2M18.5M
 
 
 
 
 
Total Operating Expenses36.2M34.3M33.1M29.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.0M-25.2M-25.3M-19.2M
 
 
 
 
 
Extraordinary Credit1.2M852.0K--0.00
 
 
 
Extraordinary Charge0.000.00-4.0M0.00
 
 
Interest Expense On Debt1.8M1.7M1.7M1.7M
 
 
 
 
 
Other Expenses721.0K-443.0K477.0K-762.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.8M-26.4M-30.5M-21.5M
 
 
 
 
 
Net Income-26.8M-26.4M-30.5M-21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS242.1M242.3M242.6M242.9M
 
 
 
 
 
Shares To Calculate EPS Diluted242.1M242.3M242.6M242.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.11-$0.13-$0.09
 
 
 
 
 
EPS Diluted-$0.11-$0.11-$0.13-$0.09